We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRH icon
326
CRH
CRH
$63.4B
$4.29M 0.04%
+57,279
New +$4.57M
IFF icon
327
International Flavors & Fragrances
IFF
$22.3B
$4.28M 0.04%
44,941
+9,891
+28% +$907K
LII icon
328
Lennox International
LII
$13.5B
$4.27M 0.04%
7,986
+2,674
+50% +$1.32M
HWM icon
329
Howmet Aerospace
HWM
$105B
$4.25M 0.04%
54,774
+2,588
+5% +$196K
EL icon
330
Estee Lauder
EL
$37.3B
$4.25M 0.04%
39,960
+911
+2% +$120K
VLTO icon
331
Veralto
VLTO
$23.9B
$4.12M 0.04%
43,122
+11,726
+37% +$1.12M
PTC icon
332
PTC
PTC
$17.2B
$4.09M 0.04%
22,492
+1,069
+5% +$191K
NDAQ icon
333
Nasdaq
NDAQ
$55.5B
$4.06M 0.04%
67,449
-353
-0.5% -$21.4K
MANH icon
334
Manhattan Associates
MANH
$13.1B
$4.04M 0.04%
16,360
-1,077
-6% -$244K
CSGP icon
335
CoStar Group
CSGP
$13.2B
$4.03M 0.04%
54,313
-15,858
-23% -$1.34M
HSY icon
336
Hershey
HSY
$36.2B
$4.01M 0.04%
21,840
-8,607
-28% -$1.67M
HAL icon
337
Halliburton
HAL
$30.1B
$4.01M 0.04%
118,667
-19,545
-14% -$721K
PPG icon
338
PPG Industries
PPG
$25.1B
$4M 0.04%
31,793
-5,751
-15% -$762K
XEL icon
339
Xcel Energy
XEL
$47.5B
$3.99M 0.04%
74,681
-95
-0.1% -$5.17K
EIX icon
340
Edison International
EIX
$27B
$3.97M 0.04%
55,352
-2,405
-4% -$174K
ZBH icon
341
Zimmer Biomet
ZBH
$19.1B
$3.96M 0.04%
36,459
-864
-2% -$102K
DG icon
342
Dollar General
DG
$27.1B
$3.95M 0.04%
29,895
-20,325
-40% -$2.84M
ON icon
343
ON Semiconductor
ON
$28.1B
$3.91M 0.04%
57,098
-426
-0.7% -$29.9K
CLX icon
344
Clorox
CLX
$12.4B
$3.88M 0.04%
28,451
+181
+0.6% +$25.1K
ES icon
345
Eversource Energy
ES
$26.6B
$3.85M 0.04%
67,935
-7,657
-10% -$454K
CHTR icon
346
Charter Communications
CHTR
$18.2B
$3.85M 0.04%
12,862
-9,686
-43% -$2.64M
WAB icon
347
Wabtec
WAB
$49.2B
$3.81M 0.04%
24,112
-515
-2% -$82.3K
BURL icon
348
Burlington
BURL
$17.3B
$3.79M 0.04%
15,803
-832
-5% -$171K
WTW icon
349
Willis Towers Watson
WTW
$32B
$3.78M 0.04%
14,433
-1,617
-10% -$417K
FITB
350
Fifth Third Bancorp
FITB
$49.3B
$3.78M 0.04%
103,661
+4,104
+4% +$150K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.